Clinical trial · Interventional
Postoperative Analgesic Effect of Subcostal TAPB for Laparoscopic Gastrectomy
Ultrasound-guided Subcostal Transversus Abdominis Plane Block in Gastric Cancer Patients Undergoing Laparoscopic Gastrectomy: A Randomized Controlled Double-blinded Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective, randomized, single blinded study is designed to evaluate the postoperative analgesic efficacy of the ultrasound-guided subcostal transversus abdominis plane block in gastric cancer patients undergoing laparoscopic gastrectomy. We hypothesize that US guided subcostal TAP block with ropivacaine can significantly reduce postoperative opioid comparison in patients with laparoscopic gastrectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Postoperative Pain | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 21G 100 mm stimulator needle (Echoplex®, Vygon, Ecouen, France) | Device | — | UNRESOLVED |
| Ropivacaine 0.75% Injectable Solution | Drug | — | UNRESOLVED |
| Ultrasound guided subcostal transversus abdominis plane block (TAPB) | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group T
- description
- Patients receiving bilateral subcostal TAP block.
- interventionNames
- Procedure: Ultrasound guided subcostal transversus abdominis plane block (TAPB)
- Drug: Ropivacaine 0.75% Injectable Solution
- Device: 21G 100 mm stimulator needle (Echoplex®, Vygon, Ecouen, France)
- type
- NO_INTERVENTION
- label
- Group C
- description
- Patients not receiving bilateral subcostal TAP block.
Primary outcomes (1)
- measure
- Total fentanyl consumption during 24 hours
- timeFrame
- postoperative 24 hours
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients scheduled to undergo elective laparoscopic gastrectomy under general anesthesia * American Society of Anesthesiologists (ASA) physical classification I-III * Consent to IV-patient controlled analgesia use * Willingness and ability to sign an informed consent document Exclusion Criteria: * Do not understand our study * Allergies to anesthetic or analgesic medications * Wound infiltration analgesia for postoperative pain control * Infection or anatomic abnormality at the needle insertion site * Pregnancy/Breast feeder * Medical or psychological disease that can affect the treatment response
References
Publications (0)
Data not yet available